Evidence map›Paper›PMID 34830146›Full record

ArticleInternational journal of molecular sciences2021

Therapeutic Effects of Inhibitor of

Seok-Hyeon Na, Hyejin Jeon, Man-Hwan Oh, Yoo-Jeong Kim, Mingi Chu, Ill-Young Lee, Je-Chul Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. A peptide targeting outer membrane protein A ofAntimicrobial agents and chemotherapy · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Factors mediatingCurrent research in microbial sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Seok-Hyeon NaDivision of Antimicrobial Resistance Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.ORCID 0000-0002-8550-9150
Hyejin JeonDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Man-Hwan OhDepartment of Microbiology, College of Science and Technology, Dankook University, Cheonan 16890, Korea.
Yoo-Jeong KimDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Mingi ChuResearch Center for Eco-Friendly New Materials, Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Ill-Young LeeResearch Center for Eco-Friendly New Materials, Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.ORCID 0000-0002-0788-430X
Je-Chul LeeDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Kyungpook National University · KRKorea Research Institute of Chemical Technology · KRDankook University · KRKorea Disease Control and Prevention Agency · KR

Funding

Korea Disease Control and Prevention Agency 2019-ER5401-01
6 · The paper itself

Abstract

The widespread of carbapenem-resistant

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnimalsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBiofilmsCarbapenemsDrug Resistance, Multiple, BacterialFemaleGene Expression Regulation, BacterialHumansMiceMice, Inbred BALB CMicrobial Sensitivity TestsPromoter Regions, GeneticSmall Molecule LibrariesAnti-Bacterial AgentsBacterial Outer Membrane ProteinsCarbapenemsOMPA outer membrane proteinsSmall Molecule LibrariesAcinetobacter baumanniianti-virulencebacteriostatic agentcompound 62520ompA promoter inhibitor

Identifiers

PMID34830146
PMCPMC8623844
OpenAlexW3214692522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.